Detail Information of Epigenetic Regulations
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0370 Transporter Info | ||||
Gene Name | SLC45A3 | ||||
Transporter Name | Solute carrier family 45 member 3 | ||||
Gene ID | |||||
UniProt ID | |||||
Epigenetic Regulations of This DT (EGR) | |||||
---|---|---|---|---|---|
Methylation |
|||||
Atypical teratoid rhabdoid tumor |
14 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC45A3 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
5'UTR (cg01455178) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.14E+00 | Statistic Test | p-value: 1.01E-08; Z-score: -1.55E+00 | ||
Methylation in Case |
7.41E-01 (Median) | Methylation in Control | 8.42E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC45A3 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
5'UTR (cg08639339) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.60E+00 | Statistic Test | p-value: 1.46E-07; Z-score: -1.35E+00 | ||
Methylation in Case |
3.21E-01 (Median) | Methylation in Control | 5.14E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC45A3 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
5'UTR (cg10581876) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.26E+00 | Statistic Test | p-value: 1.98E-07; Z-score: 1.20E+00 | ||
Methylation in Case |
2.41E-01 (Median) | Methylation in Control | 1.91E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC45A3 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
5'UTR (cg13323097) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.25E+00 | Statistic Test | p-value: 5.59E-07; Z-score: 1.21E+00 | ||
Methylation in Case |
8.96E-01 (Median) | Methylation in Control | 7.16E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC45A3 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
5'UTR (cg13791589) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.24E+00 | Statistic Test | p-value: 6.70E-07; Z-score: 1.21E+00 | ||
Methylation in Case |
7.50E-01 (Median) | Methylation in Control | 6.05E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC45A3 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
5'UTR (cg16278077) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.44E+00 | Statistic Test | p-value: 1.70E-06; Z-score: -1.26E+00 | ||
Methylation in Case |
4.19E-01 (Median) | Methylation in Control | 6.03E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC45A3 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
5'UTR (cg17504096) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.35E+00 | Statistic Test | p-value: 1.96E-06; Z-score: 1.19E+00 | ||
Methylation in Case |
7.14E-01 (Median) | Methylation in Control | 5.29E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of SLC45A3 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
5'UTR (cg17723122) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -5.40E+00 | Statistic Test | p-value: 2.18E-06; Z-score: -1.45E+00 | ||
Methylation in Case |
8.98E-02 (Median) | Methylation in Control | 4.85E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 9 |
Methylation of SLC45A3 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
5'UTR (cg25551287) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.05E+00 | Statistic Test | p-value: 9.58E-06; Z-score: -9.02E-01 | ||
Methylation in Case |
8.34E-01 (Median) | Methylation in Control | 8.74E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 10 |
Methylation of SLC45A3 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
Body (cg03374976) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.12E+00 | Statistic Test | p-value: 2.96E-04; Z-score: 7.99E-01 | ||
Methylation in Case |
7.42E-01 (Median) | Methylation in Control | 6.64E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 11 |
Methylation of SLC45A3 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
Body (cg06832359) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.13E+00 | Statistic Test | p-value: 2.98E-03; Z-score: 6.77E-01 | ||
Methylation in Case |
7.06E-01 (Median) | Methylation in Control | 6.26E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 12 |
Methylation of SLC45A3 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
Body (cg12178904) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.04E+00 | Statistic Test | p-value: 2.70E-02; Z-score: -3.94E-01 | ||
Methylation in Case |
7.88E-01 (Median) | Methylation in Control | 8.16E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 13 |
Methylation of SLC45A3 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
Body (cg14084826) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.08E+00 | Statistic Test | p-value: 4.26E-02; Z-score: -2.07E-01 | ||
Methylation in Case |
1.15E-01 (Median) | Methylation in Control | 1.24E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 14 |
Methylation of SLC45A3 in atypical teratoid rhabdoid tumor | [ 1 ] | |||
Location |
3'UTR (cg12638776) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.16E+00 | Statistic Test | p-value: 2.53E-11; Z-score: -2.11E+00 | ||
Methylation in Case |
7.60E-01 (Median) | Methylation in Control | 8.81E-01 (Median) | ||
Studied Phenotype |
Atypical teratoid rhabdoid tumor [ ICD-11: 2A00.1Y] | ||||
Experimental Material |
Patient tissue samples | ||||
Bladder cancer |
12 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC45A3 in bladder cancer | [ 2 ] | |||
Location |
5'UTR (cg08639339) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.85E+00 | Statistic Test | p-value: 6.85E-08; Z-score: -1.24E+01 | ||
Methylation in Case |
2.50E-01 (Median) | Methylation in Control | 4.62E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC45A3 in bladder cancer | [ 2 ] | |||
Location |
5'UTR (cg01455178) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.58E+00 | Statistic Test | p-value: 1.96E-06; Z-score: -7.37E+00 | ||
Methylation in Case |
4.50E-01 (Median) | Methylation in Control | 7.11E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC45A3 in bladder cancer | [ 2 ] | |||
Location |
5'UTR (cg17723122) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -2.72E+00 | Statistic Test | p-value: 9.59E-06; Z-score: -5.43E+00 | ||
Methylation in Case |
2.08E-01 (Median) | Methylation in Control | 5.66E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC45A3 in bladder cancer | [ 2 ] | |||
Location |
5'UTR (cg13791589) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.32E+00 | Statistic Test | p-value: 3.58E-02; Z-score: -1.35E+00 | ||
Methylation in Case |
2.02E-02 (Median) | Methylation in Control | 2.67E-02 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC45A3 in bladder cancer | [ 2 ] | |||
Location |
TSS1500 (cg11455040) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.50E+00 | Statistic Test | p-value: 3.07E-02; Z-score: -1.37E+00 | ||
Methylation in Case |
4.50E-02 (Median) | Methylation in Control | 6.74E-02 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC45A3 in bladder cancer | [ 2 ] | |||
Location |
TSS200 (cg21850691) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.20E+00 | Statistic Test | p-value: 6.90E-03; Z-score: -1.94E+00 | ||
Methylation in Case |
5.40E-02 (Median) | Methylation in Control | 6.47E-02 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC45A3 in bladder cancer | [ 2 ] | |||
Location |
TSS200 (cg12048674) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.37E+00 | Statistic Test | p-value: 2.59E-02; Z-score: -1.64E+00 | ||
Methylation in Case |
6.35E-02 (Median) | Methylation in Control | 8.70E-02 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of SLC45A3 in bladder cancer | [ 2 ] | |||
Location |
Body (cg06832359) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.73E+00 | Statistic Test | p-value: 1.04E-13; Z-score: -1.45E+01 | ||
Methylation in Case |
3.22E-01 (Median) | Methylation in Control | 5.58E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 9 |
Methylation of SLC45A3 in bladder cancer | [ 2 ] | |||
Location |
Body (cg26894854) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.23E+00 | Statistic Test | p-value: 1.35E-07; Z-score: -6.01E+00 | ||
Methylation in Case |
4.80E-01 (Median) | Methylation in Control | 5.93E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 10 |
Methylation of SLC45A3 in bladder cancer | [ 2 ] | |||
Location |
Body (cg27568165) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.59E+00 | Statistic Test | p-value: 8.51E-07; Z-score: -8.85E+00 | ||
Methylation in Case |
4.11E-01 (Median) | Methylation in Control | 6.52E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 11 |
Methylation of SLC45A3 in bladder cancer | [ 2 ] | |||
Location |
Body (cg14084826) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.20E+00 | Statistic Test | p-value: 4.07E-06; Z-score: -8.32E+00 | ||
Methylation in Case |
6.21E-01 (Median) | Methylation in Control | 7.46E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 12 |
Methylation of SLC45A3 in bladder cancer | [ 2 ] | |||
Location |
Body (cg12178904) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.32E+00 | Statistic Test | p-value: 7.83E-05; Z-score: -6.10E+00 | ||
Methylation in Case |
5.42E-01 (Median) | Methylation in Control | 7.14E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Breast cancer |
8 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC45A3 in breast cancer | [ 3 ] | |||
Location |
5'UTR (cg01455178) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.37E+00 | Statistic Test | p-value: 1.17E-22; Z-score: 3.33E+00 | ||
Methylation in Case |
7.34E-01 (Median) | Methylation in Control | 5.37E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC45A3 in breast cancer | [ 3 ] | |||
Location |
5'UTR (cg08639339) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.34E+00 | Statistic Test | p-value: 3.81E-16; Z-score: 3.78E+00 | ||
Methylation in Case |
5.53E-01 (Median) | Methylation in Control | 4.12E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC45A3 in breast cancer | [ 3 ] | |||
Location |
5'UTR (cg17723122) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.33E+00 | Statistic Test | p-value: 2.42E-07; Z-score: -1.31E+00 | ||
Methylation in Case |
3.90E-01 (Median) | Methylation in Control | 5.18E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC45A3 in breast cancer | [ 3 ] | |||
Location |
5'UTR (cg10581876) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.03E+00 | Statistic Test | p-value: 1.19E-05; Z-score: -1.19E+00 | ||
Methylation in Case |
8.32E-01 (Median) | Methylation in Control | 8.56E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC45A3 in breast cancer | [ 3 ] | |||
Location |
Body (cg27568165) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.24E+00 | Statistic Test | p-value: 1.73E-14; Z-score: 2.10E+00 | ||
Methylation in Case |
7.05E-01 (Median) | Methylation in Control | 5.70E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC45A3 in breast cancer | [ 3 ] | |||
Location |
Body (cg14084826) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.09E+00 | Statistic Test | p-value: 1.41E-10; Z-score: 1.55E+00 | ||
Methylation in Case |
7.58E-01 (Median) | Methylation in Control | 6.96E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC45A3 in breast cancer | [ 3 ] | |||
Location |
Body (cg12178904) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.12E+00 | Statistic Test | p-value: 1.76E-07; Z-score: 1.35E+00 | ||
Methylation in Case |
7.72E-01 (Median) | Methylation in Control | 6.90E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of SLC45A3 in breast cancer | [ 3 ] | |||
Location |
3'UTR (cg12638776) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.18E+00 | Statistic Test | p-value: 3.03E-07; Z-score: -7.78E-01 | ||
Methylation in Case |
9.45E-02 (Median) | Methylation in Control | 1.12E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Renal cell carcinoma |
4 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC45A3 in clear cell renal cell carcinoma | [ 4 ] | |||
Location |
5'UTR (cg08639339) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.09E+00 | Statistic Test | p-value: 1.40E-03; Z-score: 8.96E-01 | ||
Methylation in Case |
4.20E-01 (Median) | Methylation in Control | 3.85E-01 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC45A3 in clear cell renal cell carcinoma | [ 4 ] | |||
Location |
5'UTR (cg01455178) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.23E+00 | Statistic Test | p-value: 1.56E-03; Z-score: 2.56E+00 | ||
Methylation in Case |
6.18E-01 (Median) | Methylation in Control | 5.03E-01 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC45A3 in clear cell renal cell carcinoma | [ 4 ] | |||
Location |
TSS1500 (cg11961175) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.30E+00 | Statistic Test | p-value: 1.45E-02; Z-score: 5.79E-01 | ||
Methylation in Case |
6.95E-02 (Median) | Methylation in Control | 5.36E-02 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC45A3 in clear cell renal cell carcinoma | [ 4 ] | |||
Location |
Body (cg12178904) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 7.28E-03; Z-score: -5.99E-01 | ||
Methylation in Case |
9.02E-01 (Median) | Methylation in Control | 9.11E-01 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Colorectal cancer |
3 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC45A3 in colorectal cancer | [ 5 ] | |||
Location |
5'UTR (cg01455178) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.04E+00 | Statistic Test | p-value: 4.12E-02; Z-score: -2.64E-01 | ||
Methylation in Case |
6.90E-01 (Median) | Methylation in Control | 7.20E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC45A3 in colorectal cancer | [ 5 ] | |||
Location |
TSS1500 (cg17284384) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.06E+00 | Statistic Test | p-value: 1.58E-02; Z-score: -2.11E-01 | ||
Methylation in Case |
2.31E-02 (Median) | Methylation in Control | 2.45E-02 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC45A3 in colorectal cancer | [ 5 ] | |||
Location |
Body (cg14084826) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.02E+00 | Statistic Test | p-value: 5.85E-03; Z-score: -4.01E-01 | ||
Methylation in Case |
8.97E-01 (Median) | Methylation in Control | 9.11E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Depression |
3 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC45A3 in depression | [ 6 ] | |||
Location |
5'UTR (cg17504096) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.07E+00 | Statistic Test | p-value: 3.56E-02; Z-score: 6.40E-01 | ||
Methylation in Case |
5.50E-02 (Median) | Methylation in Control | 5.13E-02 (Median) | ||
Studied Phenotype |
Depression [ ICD-11: 6A8Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC45A3 in depression | [ 6 ] | |||
Location |
TSS1500 (cg11455040) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.08E+00 | Statistic Test | p-value: 1.78E-02; Z-score: 5.02E-01 | ||
Methylation in Case |
8.15E-02 (Median) | Methylation in Control | 7.54E-02 (Median) | ||
Studied Phenotype |
Depression [ ICD-11: 6A8Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC45A3 in depression | [ 6 ] | |||
Location |
TSS200 (cg00305188) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.06E+00 | Statistic Test | p-value: 2.74E-02; Z-score: 5.47E-01 | ||
Methylation in Case |
7.64E-02 (Median) | Methylation in Control | 7.21E-02 (Median) | ||
Studied Phenotype |
Depression [ ICD-11: 6A8Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Hepatocellular carcinoma |
13 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC45A3 in hepatocellular carcinoma | [ 7 ] | |||
Location |
5'UTR (cg16278077) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.02E+00 | Statistic Test | p-value: 3.82E-07; Z-score: 7.14E-01 | ||
Methylation in Case |
9.34E-01 (Median) | Methylation in Control | 9.18E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC45A3 in hepatocellular carcinoma | [ 7 ] | |||
Location |
5'UTR (cg01455178) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.24E+00 | Statistic Test | p-value: 1.92E-06; Z-score: 1.35E+00 | ||
Methylation in Case |
5.33E-01 (Median) | Methylation in Control | 4.30E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC45A3 in hepatocellular carcinoma | [ 7 ] | |||
Location |
5'UTR (cg10581876) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.21E+00 | Statistic Test | p-value: 2.03E-03; Z-score: -9.11E-01 | ||
Methylation in Case |
4.66E-01 (Median) | Methylation in Control | 5.65E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC45A3 in hepatocellular carcinoma | [ 7 ] | |||
Location |
5'UTR (cg08639339) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.03E+00 | Statistic Test | p-value: 1.18E-02; Z-score: 2.28E-01 | ||
Methylation in Case |
3.91E-01 (Median) | Methylation in Control | 3.78E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC45A3 in hepatocellular carcinoma | [ 7 ] | |||
Location |
TSS200 (cg07061355) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.68E+00 | Statistic Test | p-value: 2.11E-18; Z-score: -7.00E+00 | ||
Methylation in Case |
4.60E-01 (Median) | Methylation in Control | 7.75E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC45A3 in hepatocellular carcinoma | [ 7 ] | |||
Location |
Body (cg13945442) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.45E+00 | Statistic Test | p-value: 7.84E-21; Z-score: -4.35E+00 | ||
Methylation in Case |
4.05E-01 (Median) | Methylation in Control | 5.89E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC45A3 in hepatocellular carcinoma | [ 7 ] | |||
Location |
Body (cg00465739) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.49E+00 | Statistic Test | p-value: 2.11E-16; Z-score: -2.32E+00 | ||
Methylation in Case |
4.44E-01 (Median) | Methylation in Control | 6.60E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of SLC45A3 in hepatocellular carcinoma | [ 7 ] | |||
Location |
Body (cg24121906) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.44E+00 | Statistic Test | p-value: 3.28E-16; Z-score: -5.36E+00 | ||
Methylation in Case |
5.50E-01 (Median) | Methylation in Control | 7.94E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 9 |
Methylation of SLC45A3 in hepatocellular carcinoma | [ 7 ] | |||
Location |
Body (cg13988611) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.59E+00 | Statistic Test | p-value: 2.47E-15; Z-score: -2.76E+00 | ||
Methylation in Case |
4.80E-01 (Median) | Methylation in Control | 7.64E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 10 |
Methylation of SLC45A3 in hepatocellular carcinoma | [ 7 ] | |||
Location |
Body (cg26894854) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.13E+00 | Statistic Test | p-value: 6.37E-08; Z-score: 1.45E+00 | ||
Methylation in Case |
5.82E-01 (Median) | Methylation in Control | 5.13E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 11 |
Methylation of SLC45A3 in hepatocellular carcinoma | [ 7 ] | |||
Location |
Body (cg03374976) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.07E+00 | Statistic Test | p-value: 6.16E-05; Z-score: 7.54E-01 | ||
Methylation in Case |
5.07E-01 (Median) | Methylation in Control | 4.75E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 12 |
Methylation of SLC45A3 in hepatocellular carcinoma | [ 7 ] | |||
Location |
Body (cg12178904) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.03E+00 | Statistic Test | p-value: 1.71E-04; Z-score: 1.04E+00 | ||
Methylation in Case |
7.87E-01 (Median) | Methylation in Control | 7.62E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 13 |
Methylation of SLC45A3 in hepatocellular carcinoma | [ 7 ] | |||
Location |
Body (cg27568165) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.02E+00 | Statistic Test | p-value: 1.31E-02; Z-score: 4.59E-01 | ||
Methylation in Case |
7.49E-01 (Median) | Methylation in Control | 7.36E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
HIV infection |
9 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC45A3 in HIV infection | [ 8 ] | |||
Location |
5'UTR (cg01455178) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.16E+00 | Statistic Test | p-value: 2.28E-16; Z-score: 2.38E+00 | ||
Methylation in Case |
8.68E-01 (Median) | Methylation in Control | 7.49E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC45A3 in HIV infection | [ 8 ] | |||
Location |
5'UTR (cg08639339) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.24E+00 | Statistic Test | p-value: 7.36E-10; Z-score: 2.38E+00 | ||
Methylation in Case |
5.45E-01 (Median) | Methylation in Control | 4.39E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC45A3 in HIV infection | [ 8 ] | |||
Location |
5'UTR (cg10581876) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.02E+00 | Statistic Test | p-value: 1.82E-03; Z-score: 9.12E-01 | ||
Methylation in Case |
8.96E-01 (Median) | Methylation in Control | 8.78E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC45A3 in HIV infection | [ 8 ] | |||
Location |
5'UTR (cg17723122) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.05E+00 | Statistic Test | p-value: 2.53E-02; Z-score: -8.57E-01 | ||
Methylation in Case |
7.18E-01 (Median) | Methylation in Control | 7.57E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC45A3 in HIV infection | [ 8 ] | |||
Location |
TSS1500 (cg11961175) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.43E+00 | Statistic Test | p-value: 6.98E-05; Z-score: 1.52E+00 | ||
Methylation in Case |
1.63E-01 (Median) | Methylation in Control | 1.14E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC45A3 in HIV infection | [ 8 ] | |||
Location |
TSS1500 (cg17284384) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.47E+00 | Statistic Test | p-value: 2.48E-03; Z-score: 7.72E-01 | ||
Methylation in Case |
1.61E-02 (Median) | Methylation in Control | 1.10E-02 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC45A3 in HIV infection | [ 8 ] | |||
Location |
TSS200 (cg12048674) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.29E+00 | Statistic Test | p-value: 1.01E-03; Z-score: 1.19E+00 | ||
Methylation in Case |
7.40E-02 (Median) | Methylation in Control | 5.74E-02 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of SLC45A3 in HIV infection | [ 8 ] | |||
Location |
Body (cg03374976) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.09E+00 | Statistic Test | p-value: 1.25E-03; Z-score: -1.71E+00 | ||
Methylation in Case |
6.54E-01 (Median) | Methylation in Control | 7.11E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 9 |
Methylation of SLC45A3 in HIV infection | [ 8 ] | |||
Location |
Body (cg14084826) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.02E+00 | Statistic Test | p-value: 2.31E-03; Z-score: 4.35E-01 | ||
Methylation in Case |
8.05E-01 (Median) | Methylation in Control | 7.93E-01 (Median) | ||
Studied Phenotype |
HIV infection [ ICD-11: 1C62.Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Lung adenocarcinoma |
6 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC45A3 in lung adenocarcinoma | [ 9 ] | |||
Location |
5'UTR (cg10581876) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.04E+00 | Statistic Test | p-value: 6.91E-03; Z-score: 1.79E+00 | ||
Methylation in Case |
8.79E-01 (Median) | Methylation in Control | 8.48E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC45A3 in lung adenocarcinoma | [ 9 ] | |||
Location |
TSS1500 (cg02075570) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.76E+00 | Statistic Test | p-value: 4.26E-04; Z-score: -2.66E+00 | ||
Methylation in Case |
7.77E-02 (Median) | Methylation in Control | 1.37E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC45A3 in lung adenocarcinoma | [ 9 ] | |||
Location |
TSS1500 (cg11455040) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.41E+00 | Statistic Test | p-value: 1.99E-03; Z-score: -1.83E+00 | ||
Methylation in Case |
1.22E-01 (Median) | Methylation in Control | 1.72E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC45A3 in lung adenocarcinoma | [ 9 ] | |||
Location |
TSS1500 (cg17284384) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.92E+00 | Statistic Test | p-value: 3.85E-03; Z-score: -1.94E+00 | ||
Methylation in Case |
3.23E-02 (Median) | Methylation in Control | 6.18E-02 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC45A3 in lung adenocarcinoma | [ 9 ] | |||
Location |
TSS1500 (cg11961175) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.23E+00 | Statistic Test | p-value: 9.68E-03; Z-score: -9.09E-01 | ||
Methylation in Case |
1.95E-01 (Median) | Methylation in Control | 2.39E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC45A3 in lung adenocarcinoma | [ 9 ] | |||
Location |
Body (cg03374976) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.16E+00 | Statistic Test | p-value: 7.38E-03; Z-score: 1.53E+00 | ||
Methylation in Case |
6.00E-01 (Median) | Methylation in Control | 5.16E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Panic disorder |
2 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC45A3 in panic disorder | [ 10 ] | |||
Location |
5'UTR (cg17723122) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.18E+00 | Statistic Test | p-value: 1.30E-03; Z-score: 7.02E-01 | ||
Methylation in Case |
1.59E+00 (Median) | Methylation in Control | 1.35E+00 (Median) | ||
Studied Phenotype |
Panic disorder [ ICD-11: 6B01] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC45A3 in panic disorder | [ 10 ] | |||
Location |
5'UTR (cg08639339) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -9.01E-01 | Statistic Test | p-value: 4.82E-02; Z-score: -3.47E-01 | ||
Methylation in Case |
-8.60E-01 (Median) | Methylation in Control | -7.75E-01 (Median) | ||
Studied Phenotype |
Panic disorder [ ICD-11: 6B01] | ||||
Experimental Material |
Patient tissue samples | ||||
Papillary thyroid cancer |
7 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC45A3 in papillary thyroid cancer | [ 11 ] | |||
Location |
5'UTR (cg10581876) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 1.30E-05; Z-score: -1.06E+00 | ||
Methylation in Case |
9.20E-01 (Median) | Methylation in Control | 9.31E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC45A3 in papillary thyroid cancer | [ 11 ] | |||
Location |
TSS200 (cg12048674) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.07E+00 | Statistic Test | p-value: 2.69E-02; Z-score: 4.02E-01 | ||
Methylation in Case |
6.18E-02 (Median) | Methylation in Control | 5.78E-02 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC45A3 in papillary thyroid cancer | [ 11 ] | |||
Location |
Body (cg12178904) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.02E+00 | Statistic Test | p-value: 2.13E-05; Z-score: -8.58E-01 | ||
Methylation in Case |
8.77E-01 (Median) | Methylation in Control | 8.96E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC45A3 in papillary thyroid cancer | [ 11 ] | |||
Location |
Body (cg26894854) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.09E+00 | Statistic Test | p-value: 5.22E-04; Z-score: 1.58E+00 | ||
Methylation in Case |
6.40E-01 (Median) | Methylation in Control | 5.88E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC45A3 in papillary thyroid cancer | [ 11 ] | |||
Location |
Body (cg03374976) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.06E+00 | Statistic Test | p-value: 1.93E-03; Z-score: 8.37E-01 | ||
Methylation in Case |
5.33E-01 (Median) | Methylation in Control | 5.04E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC45A3 in papillary thyroid cancer | [ 11 ] | |||
Location |
Body (cg14084826) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 3.46E-03; Z-score: -3.80E-01 | ||
Methylation in Case |
8.24E-01 (Median) | Methylation in Control | 8.34E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SLC45A3 in papillary thyroid cancer | [ 11 ] | |||
Location |
Body (cg27568165) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 3.69E-03; Z-score: -2.79E-01 | ||
Methylation in Case |
8.16E-01 (Median) | Methylation in Control | 8.24E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Systemic lupus erythematosus |
6 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC45A3 in systemic lupus erythematosus | [ 12 ] | |||
Location |
5'UTR (cg08639339) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.07E+00 | Statistic Test | p-value: 1.41E-03; Z-score: 3.49E-01 | ||
Methylation in Case |
6.58E-01 (Median) | Methylation in Control | 6.17E-01 (Median) | ||
Studied Phenotype |
Systemic lupus erythematosus [ ICD-11: 4A40.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC45A3 in systemic lupus erythematosus | [ 12 ] | |||
Location |
5'UTR (cg13323097) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.03E+00 | Statistic Test | p-value: 5.39E-03; Z-score: 1.73E-01 | ||
Methylation in Case |
1.83E-01 (Median) | Methylation in Control | 1.78E-01 (Median) | ||
Studied Phenotype |
Systemic lupus erythematosus [ ICD-11: 4A40.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC45A3 in systemic lupus erythematosus | [ 12 ] | |||
Location |
5'UTR (cg01455178) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.01E+00 | Statistic Test | p-value: 3.43E-02; Z-score: 2.64E-01 | ||
Methylation in Case |
8.84E-01 (Median) | Methylation in Control | 8.72E-01 (Median) | ||
Studied Phenotype |
Systemic lupus erythematosus [ ICD-11: 4A40.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC45A3 in systemic lupus erythematosus | [ 12 ] | |||
Location |
5'UTR (cg13791589) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.04E+00 | Statistic Test | p-value: 4.11E-02; Z-score: -1.04E-01 | ||
Methylation in Case |
2.97E-02 (Median) | Methylation in Control | 3.08E-02 (Median) | ||
Studied Phenotype |
Systemic lupus erythematosus [ ICD-11: 4A40.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC45A3 in systemic lupus erythematosus | [ 12 ] | |||
Location |
TSS1500 (cg17284384) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.08E+00 | Statistic Test | p-value: 5.52E-04; Z-score: 1.92E-01 | ||
Methylation in Case |
1.84E-02 (Median) | Methylation in Control | 1.71E-02 (Median) | ||
Studied Phenotype |
Systemic lupus erythematosus [ ICD-11: 4A40.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SLC45A3 in systemic lupus erythematosus | [ 12 ] | |||
Location |
Body (cg14084826) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 2.99E-02; Z-score: -1.85E-01 | ||
Methylation in Case |
8.34E-01 (Median) | Methylation in Control | 8.40E-01 (Median) | ||
Studied Phenotype |
Systemic lupus erythematosus [ ICD-11: 4A40.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Colon cancer |
4 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC45A3 in colon adenocarcinoma | [ 13 ] | |||
Location |
TSS1500 (cg23909013) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.79E+00 | Statistic Test | p-value: 2.58E-04; Z-score: 3.48E+00 | ||
Methylation in Case |
3.39E-01 (Median) | Methylation in Control | 1.90E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC45A3 in colon adenocarcinoma | [ 13 ] | |||
Location |
TSS200 (cg00111823) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 1.13E-03; Z-score: -1.41E+00 | ||
Methylation in Case |
9.41E-01 (Median) | Methylation in Control | 9.50E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC45A3 in colon adenocarcinoma | [ 13 ] | |||
Location |
TSS200 (cg19766441) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 2.27E+00 | Statistic Test | p-value: 2.17E-03; Z-score: 2.22E+00 | ||
Methylation in Case |
2.60E-01 (Median) | Methylation in Control | 1.15E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC45A3 in colon adenocarcinoma | [ 13 ] | |||
Location |
Body (cg15526153) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.06E+00 | Statistic Test | p-value: 2.77E-04; Z-score: -2.05E+00 | ||
Methylation in Case |
7.67E-01 (Median) | Methylation in Control | 8.10E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Pancretic ductal adenocarcinoma |
5 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC45A3 in pancretic ductal adenocarcinoma | [ 14 ] | |||
Location |
TSS1500 (cg20982412) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.30E+00 | Statistic Test | p-value: 4.87E-20; Z-score: 4.79E+00 | ||
Methylation in Case |
4.20E-01 (Median) | Methylation in Control | 3.22E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC45A3 in pancretic ductal adenocarcinoma | [ 14 ] | |||
Location |
TSS1500 (cg13948585) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.89E+00 | Statistic Test | p-value: 8.15E-18; Z-score: 3.56E+00 | ||
Methylation in Case |
2.94E-01 (Median) | Methylation in Control | 1.56E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC45A3 in pancretic ductal adenocarcinoma | [ 14 ] | |||
Location |
TSS200 (cg12005098) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 2.29E+00 | Statistic Test | p-value: 1.15E-21; Z-score: 3.76E+00 | ||
Methylation in Case |
1.43E-01 (Median) | Methylation in Control | 6.23E-02 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC45A3 in pancretic ductal adenocarcinoma | [ 14 ] | |||
Location |
Body (cg25253677) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 2.47E+00 | Statistic Test | p-value: 3.24E-09; Z-score: 1.33E+00 | ||
Methylation in Case |
1.59E-01 (Median) | Methylation in Control | 6.46E-02 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SLC45A3 in pancretic ductal adenocarcinoma | [ 14 ] | |||
Location |
3'UTR (cg19877765) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.10E+00 | Statistic Test | p-value: 3.70E-02; Z-score: -1.06E+00 | ||
Methylation in Case |
4.39E-01 (Median) | Methylation in Control | 4.82E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Prostate cancer |
4 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SLC45A3 in prostate cancer | [ 15 ] | |||
Location |
TSS1500 (cg05671585) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.69E+00 | Statistic Test | p-value: 9.42E-03; Z-score: 3.69E+00 | ||
Methylation in Case |
5.16E-02 (Median) | Methylation in Control | 3.04E-02 (Median) | ||
Studied Phenotype |
Prostate cancer [ ICD-11: 2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SLC45A3 in prostate cancer | [ 15 ] | |||
Location |
TSS200 (cg00881552) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.16E+00 | Statistic Test | p-value: 3.00E-03; Z-score: 3.77E+00 | ||
Methylation in Case |
1.35E-01 (Median) | Methylation in Control | 1.16E-01 (Median) | ||
Studied Phenotype |
Prostate cancer [ ICD-11: 2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SLC45A3 in prostate cancer | [ 15 ] | |||
Location |
TSS200 (cg21636683) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.33E+00 | Statistic Test | p-value: 7.27E-03; Z-score: 2.98E+00 | ||
Methylation in Case |
8.00E-01 (Median) | Methylation in Control | 6.00E-01 (Median) | ||
Studied Phenotype |
Prostate cancer [ ICD-11: 2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SLC45A3 in prostate cancer | [ 15 ] | |||
Location |
Body (cg21644011) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.07E+00 | Statistic Test | p-value: 2.40E-02; Z-score: 2.02E+00 | ||
Methylation in Case |
9.26E-01 (Median) | Methylation in Control | 8.69E-01 (Median) | ||
Studied Phenotype |
Prostate cancer [ ICD-11: 2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
microRNA |
|||||
Unclear Phenotype |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
miR-218 directly targets SLC45A3 | [ 16 ] | |||
Epigenetic Type |
microRNA | Experiment Method | HITS-CLIP | ||
miRNA Stemloop ID |
miR-218 | miRNA Mature ID | miR-218-5p | ||
miRNA Sequence |
UUGUGCUUGAUCUAACCAUGU | ||||
miRNA Target Type |
Direct | ||||
Experimental Material |
Multiple cell lines of human | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.